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Poly-N-isopropylacrylamide (pNIPAM): a 
reversible bioadhesive for sclerotomy closure
Luiz H. Lima1,2*, Yael Morales1 and Thiago Cabral2
Abstract 
Purpose: To determine the safety and efficacy of poly-N-isopropylacrylamide, a thermoresponsive adhesive, for 
sutureless sclerotomy closure in rabbits.
Methods: Eight rabbits were randomized into three groups: short-term acute, mid-term chronic, and long-term 
chronic studies. A corresponding control group in which the scleral wounds were sutured by 6–0 vicryl sutures was 
assigned for each study group. A 20-gauge sclerotomy was performed following a core vitrectomy and 0.1 mL of 
50 % liquid poly-N-isopropylacrylamide was applied to the scleral wounds. Before the polymer application, the scleral 
surface was raised above 32 °C using a halogen bulb lamp. Follow-up exams included color external and fundus 
photography, fundus fluorescein angiography, optical coherence tomography, and electroretinography. After the 
last follow-up assessment, the rabbits were sacrificed and histopathological studies on the scleral incision sites were 
performed.
Results: Scleral wound healing was observed in the long-term chronic study rabbits. Histological studies were able 
to identify poly-N-isopropylacrylamide polymer at the sclerotomy site in the mid-term chronic study rabbits. Besides 
iatrogenic cataracts due to mechanical instrument touch in 2 rabbits, no other ocular abnormalities were identified 
in any of the eyes in the perioperative setting or during the follow-up period. Cornea, retina, and vitreous remained 
unaffected, and no abnormal inflammatory reaction or endophthalmitis was noticed in the 3 study groups. Filtering 
blebs indicative of leakage through the sclerotomies were not observed during the follow-up period.
Conclusion: Poly-N-isopropylacrylamide may provide effective in vitro scleral adhesion above 32 °C. Clinical studies 
are required to evaluate its utility in patients undergoing pars plana vitrectomy.
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Background
Even with the advent of smaller gauge surgery, a num-
ber of pars plana vitrectomies continue to be performed 
using 20 gauge incisions that require sutures for closure 
[1–3]. The sutures that are commonly used to close the 
sclerotomies can induce granulomas, inflammation, irri-
tation, and astigmatism. Moreover, some smaller gauge 
sutureless incisions may not be water-tight, leading to 
hypotony and an increased incidence of endophthalmitis. 
Bioadhesives such as cyanoacrylate and fibrin glue have 
been used to close leaking sclerotomies after vitrectomy 
surgery. However, the use of these compounds resulted 
in complications such as incomplete sclerotomy closure, 
ocular hypotony and surface roughness leading to ocular 
irritation [4–6].
The use of thermally responsive polymers in biomedi-
cal applications has been widely investigated. Thermally 
responsive polymers exhibit a lower critical solution tem-
perature (LCST), below which the polymers are soluble. 
When the temperature is raised above the LCST, these 
polymers first undergo a phase transition; they then col-
lapse and form aggregates. This phenomenon is revers-
ible such that when the temperature is lowered, the 
polymers once again become soluble [7].
Poly-N-isopropylacrylamide (pNIPAM) is a thermo-
responsive polymer with inverse solubility and a 
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reversible phase transition upon heating [8]. It has an 
LCST value of approximately 32  °C. Below 32  °C, it is 
hydrophilic and water soluble; above 32  °C, it is hydro-
phobic and becomes a viscous gel that is strongly adher-
ent to tissue. pNIPAM is soluble at room temperature, 
but it phase separates at body temperature (37  °C); it 
therefore can be used as a linear polymer, a hydrogel, 
or a copolymer [9–12]. For example, pNIPAM has been 
used for drug targeting in solid tumors with local hyper-
thermia and in thermosensitive coatings or micelles for 
controlled release of the drug. In addition, pNIPAM pol-
ymers have been used in eye drop preparations and as a 
new embolic material in neurosurgery [13–15].
Although pNIPAM has been studied as a new ocular 
drug delivery platform to the posterior segment of the 
eye and as an adhesive for retinal implants [16–20] there 
is no report regarding its application for scleral wound 
healing. The purpose of the present feasibility study was 
to evaluate the safety and efficacy of pNIPAM as an adhe-
sive for the closure of sclerotomies.
Methods
pNIPAM synthesis
We synthesized pNIPAM through bulk polymerization of 
1.0 g of N-isopropylacrylamide with 0.0145 g of 2,2-azo-
bisisobutyronitrile in 14 mL of ethanol. The mixture was 
heated in an oil bath set at 65 °C for 16 h under constant 
stirring. After the ethanol was removed under vacuum, 
the polymer was dissolved in a minimal amount of tet-
rahydrofuran and recrystalized by the addition of ether. 
The solid precipitates were collected and air dried. The 
solid pNIPAM was then dissolved in phosphate-buffered 
saline at different concentrations (20, 30, and 50 %).
pNIPAM in vivo studies
In preliminary studies, we examined the use of pNIPAM 
for sclerotomy closure in 10 enucleated porcine eyes 
(Sierra for Medical Science, Whittier, CA, USA). Fol-
lowing a conjunctiva sectioning, a two-port pars plana 
vitrectomy was performed in the porcine eye with a 
20-gauge system (Bausch & Lomb, Rochester, NY USA) 
using perpendicular scleral incisions. A 20-gauge MVR 
blade was used for the 2 sclerotomies (one for the infu-
sion line and the other for the vitreous cutter). We 
performed a core vitrectomy using a Millenium Micro-
surgical System (Bausch & Lomb, Rochester, New York, 
USA) and the patency of the 20-gauge sclerotomy was 
confirmed by visualizing room temperature balanced 
salt solution (BSS, Baxter, Deerfield, Illinois, USA) flow 
through the sclerotomy. Then, the scleral surface was 
dried with cotton-tips, and the scleral temperature was 
raised above 32 °C using a halogen bulb lamp. The scle-
ral temperature was monitored with a thermocoupled 
24-gauge hypodermic probe (Omega Engineering, Inc., 
Stamford, CT, USA) connected to a tele-thermometer 
(model DP 460-T Omega Engineering, Inc., Stamford, 
CT, USA) and placed on the scleral surface immediately 
adjacent to the applied glue. An amount of 0.1 mL of liq-
uid pNIPAM was applied at various concentrations (20, 
30, and 50 %) to the sclerotomy wounds. After allowing 
the pNIPAM to dry for a few minutes, we turned on the 
infusion fluid which contained fluorescein dye. The bottle 
with BSS was raised until leakage was noted through the 
scleral wound (Fig.  1). The temperature was monitored 
and kept above 32 °C during the entire experiment. In the 
control group, seven scleral wounds were left untreated 
and six wounds were closed with a traditional 3-pass run-
ning configuration by 6–0 vicryl suture. Before the scle-
rotomy closure, these porcine eyes underwent the same 
surgical protocol used for the study group.
Animals were used in accordance with the ARVO 
statement on the Use of Animals in Ophthalmic and 
Visual Research. After Institutional Animal Care and Use 
committee and institutional review board approval from 
the University of California Los Angeles (UCLA), a total 
of 16 animals were used in the present study. Eight New 
Zealand pigmented rabbits weighing between 2 and 4 kg 
were randomized into three groups for the short-term 
acute (2 h), mid-term chronic (14 and 30 days), and long-
term chronic (6 months) studies. Eight animals were used 
for controls as described below.
In the short-term acute study, pNIPAM was applied to 
the 20-gauge sclerotomies in four rabbit eyes for 2 h and 
the sclerotomy was monitored while the bottle height 
was kept constant at 70 mmHg. Scleral temperature was 
maintained above 32  °C in 2 rabbits and was allowed to 
decrease without heating to 20 °C in the other 2 rabbits. 
The four rabbits in the short-term acute study were euth-
anized by intracardiac injection of pentobarbital after 2 h 
of observation. In the mid-term chronic study, pNIPAM 
was applied to the sclerotomy in two rabbits; one of these 
rabbits was followed up for 14  days and the second for 
30  days. In the long-term chronic study, pNIPAM was 
applied to 2 rabbits which were followed up for 6 months. 
In all study rabbits, pNIPAM was applied in a concentra-
tion of 50 %.
A two-port pars plana vitrectomy was performed in 
the rabbit eye with a 20-gauge system (Bausch & Lomb, 
Rochester, NY USA) using perpendicular scleral inci-
sions after conjunctiva sectioning. The 20-gauge scle-
rotomy procedure was performed using a MVR blade 
and under sterile conditions using an operating micro-
scope. A speculum was used to keep the eyelids open. 
Two sclerotomies were performed at a distance of 180 
degree from each other, one was for the infusion cannula 
and the other for the vitreous cutter. A core vitrectomy 
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was performed using a Millenium Microsurgical System 
(Bausch & Lomb, Rochester, New York, USA). Following 
the documenting of the patency of the sclerotomy as evi-
denced by efflux of BSS from the sclerotomy, the scleral 
surface was dried with cotton-tips before the polymer 
application and the scleral temperature was raised above 
32  °C using a halogen bulb lamp. Liquid pNIPAM was 
applied with a 1  mL syringe to the temporal quadrant 
sclerotomy in the same amount (0.1 mL) and concentra-
tion (50 %) in all rabbits. The study animals were carefully 
examined by trained veterinarians during the surgical 
procedure and in the postoperative follow-up period. For 
each of the 3 study groups, there was a corresponding 
control group with equal number of rabbits that under-
went identical surgical protocol before the sclerotomy 
closure. In this control group, the scleral wounds were 
sutured by 6–0 vicryl sutures using a traditional 3-pass 
running configuration and conjunctival wounds by 8–0 
vicryl sutures.
At regular intervals, the rabbits underwent routine 
evaluations, including slit-lamp examination, intraocular 
pressure measurement, indirect ophthalmoscopy, exter-
nal and fundus color photography, fundus fluorescein 
angiography (FA), optical coherence tomography (OCT) 
and electroretinography (ERG). Slit- lamp examinations 
and indirect ophthalmoscopy were performed preopera-
tively, immediately after injection and on days 1, 2, 4, 7, 
and 14, and monthly thereafter for 6 months. Intraocular 
pressure was measured with a tonometer at each exami-
nation. OCT, FA, and external and fundus photogra-
phy were performed preoperatively, on day 14 and then 
monthly for 6  months. ERGs were recorded preopera-
tively, on day 14 (one rabbit), and monthly thereafter, 
using an Espion Visual Electrophysiology unit (Diagnosys 
LLC, Lowell, MA, USA) [21, 22].
After the last follow-up examination, the rabbits were 
sacrificed using an intracardiac injection of pentobarbi-
tal. Then, the eyes were enucleated, placed in Davidson 
fixative medium and inserted in paraffin before section-
ing. Histological studies were performed in all study eyes. 
Tissue slices of 10 um from the frozen sections were 
cut until the sclerotomy location was reached and were 
stained with hematoxylin and eosin. Digital photographs 
from histological slides were taken and studied using 
NIH Image software (version 1.62, National Institutes of 
Health, Bethesda, MD).
Results
In our preliminary studies in the ten enucleated porcine 
eyes using 20 and 30  % pNIPAM, leakage through the 
sclerotomies occurred at a pressure of 10 mmHg of bottle 
height. With the higher concentration of 50 % pNIPAM, 
no leakage was observed until 80 mmHg of bottle height. 
The untreated wounds leaked at a pressure of 5 mmHg of 
bottle height, and the sutured wounds leaked at a pres-
sure of 70 mmHg.
Fig. 1 a–f Sequence of events in the porcine eye experiment. a Core vitrectomy before patency of balanced salted solution (BSS) flow through the 
sclerotomy. b The thermocouple measuring the sclera temperature to confirm levels higher than 31 °C. c Fluorescein dye injection in the infusion 
line before the adhesive placement for a better visualization of the BSS flow through the sclerotomy. d Removal of 50 % liquid poly-N-isopropy-
lacrylamide (PNIPAM). e PNIPAM application on the 20-gauge sclerotomy site. f BSS leakage through the sclerotomy wound at 80 mmHg bottle 
height
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For the eight rabbits used in this study, no mechanical 
lesions apart from the application sites themselves were 
observed from the glue application. The liquid polymer 
spread out and stuck to the conjunctiva around the scle-
rotomy wound in three rabbits. In each of the eyes with 
scleral temperature of 32 °C or above that received pNI-
PAM, a smooth and shallow white halo corresponding to 
the pNIPAM glue appeared around the sclerotomy site 
immediately after injection. The size and shape of the 
polymerized glue continued unchanged during the follow 
up period in all of the eyes. In the two rabbits in which 
the temperature was below 32 °C, the pNIPAM glue was 
not able to polymerize and stick to the scleral tissue as 
expected.
The efficacy of the scleral closure was evaluated by reg-
ular examinations. There was excellent wound closure of 
the scleral incisions both at the time of surgery and at the 
time of sacrifice. No animal showed any signs of wound 
dehiscence, infection, or cyst formation at any time. At 
2  weeks, all incisions were well healed and difficult to 
detect via slit lamp biomicroscopy. No filtering bleb was 
noted indicative of leakage through the sclerotomies dur-
ing the follow-up period. Similar results were observed 
through the six month period of the long-term chronic 
experiment (Fig. 2). Less inflammatory reaction occurred 
in the group of rabbits in which the scleral wound was 
closed with pNIPAM than in those rabbits in which vic-
ryl sutures were used.
Except for small posterior subcapsular cataracts in two 
rabbits caused by accidental lens contact during the vit-
rectomy, no ocular abnormalities were noted in any of the 
eyes in the perioperative settings or during the follow-up 
period. Cornea, retina, and vitreous remained unaffected, 
and no abnormal inflammatory reaction or endophthal-
mitis was observed. Intraocular pressure remained nor-
mal, ranging from 11 to 18  mmHg (mean: 14  mmHg). 
The difference in intraocular pressure between the two 
eyes of each animal was always less than 4 mmHg at each 
examination.
Fundus color photographs, OCT, and FA revealed no 
significant abnormalities during the follow-up period 
(Fig.  3). Throughout the course of the study, the mean 
b-wave amplitude ratios of ERG recordings (eyes with 
pNIPAM/left eyes) remained close to 1. Paired compari-
sons of the preoperative b-wave ratios versus the ratios at 
each time period showed no significant differences when 
evaluated with the Student t test.
In the histologic sections, at the sclerotomy sites of the 
2 rabbits from the mid-term chronic study group (14 and 
30 days follow-up), a foreign body corresponding to pNI-
PAM material was observed. Wound healing without any 
existence of glue and a smooth overlying conjuctiva were 
observed at the sclerotomy site in the long-term chronic 
group (6 months follow-up). No abnormal fibrous prolif-
eration or vitreous incarceration was identified in the his-
tologic sections (Fig. 4).
Discussion
Currently, 20-gauge sclerotomy wounds are usually 
closed with sutures, while most 23-gauge and 25-gauge 
wounds are considered to be self-sealing. Closure with 
sutures increases the chance of causing changes in the 
curvature of the eye, possibly resulting in refractive 
problems and slowing postoperative recovery [23, 24]. 
Sometimes, “self-sealing” sclerotomies continue to leak, 
leading to complications such as ocular hypotony and 
endophthalmitis [25, 26].
The ideal adhesive for extras- or intraocular use should 
be nontoxic, biocompatible, tolerated by ocular tissue 
(i.e., smooth surface), and inexpensive. Previous reports 
showed that adhesives such as cyanoacrylate and fibrin 
glue were ineffective for use in sclerotomy closure [4–6] 
Although N-isopropylacrylamide monomer is toxic to 
neural tissue, after polymerization, the pNIPAM mole-
cule is no longer toxic. It is commonly used, for example, 
in cell and tissue cultures for its reversible cell adhesion 
properties. Interestingly, pNIPAM has also been used to 
stop bleeding in experimental liver injuries and no tox-
icity has been reported. This thermoresponsive, “smart” 
polymer has been postulated to have other potential 
Fig. 2 a–d External color photographs showing the appearance of 
the conjunctiva over the sclerotomy wound site 15 days (a), 1 month 
(b), 3 months (c), and 6 months (d) after the surgical procedure 
in one of the 8 study rabbits. The conjunctiva swelling decreased 
through the follow-up period
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applications in ophthalmic surgery and drug delivery 
[27–31].
In our feasibility study, pNIPAM was used to close 
20-gauge sclerotomy wounds in rabbit eyes. The pNI-
PAM liquid has a low viscosity and is of a white color. 
The best bond strength is achieved by using a thin film 
of the glue. The adhesive formed an immediate strong 
bond between the scleral edges in an easy and reproduc-
ible manner. During surgery, the adhesive polymerized 
within a few minutes and had the necessary strength 
for initiation and maintenance of scleral apposition. As 
the pNIPAM glue polymerizes quickly inside the needle 
before application, we use a syringe without a needle. 
Consequently, a precise glue application was somewhat 
difficult to achieve since the glue spread out beyond the 
sclera incision edges. Future studies can better address 
the question of application. One also must be careful to 
isolate the conjunctival wound edges because any stray 
adhesive can easily glue other ocular structures.
The local effects of pNIPAM on follow up examina-
tion were minimal. A slit-lamp examination of the glue 
application site showed only moderate inflammatory 
changes at 1  week and only mild conjunctival hyper-
emia by 2 weeks. No ocular inflammatory signals were 
noticed by 4 weeks. Thus, the adhesive seems to be well 
tolerated by rabbit tissues. The adhesive bond is also a 
flexible bandage, which covers the entire scleral wound. 
Theoretically, this should decrease the possibility of 
postoperative bacterial contamination of the vitreous 
cavity. Thus, it can reduce the chance of endophthal-
mitis after vitrectomy surgery. Another advantage of 
pNIPAM could be a reduction in the chances of postop-
erative astigmatism in comparison with scleral wounds 
closed by sutures.
In the acute setting, with 20-gauge sclerotomies, there 
were no relevant complications such as low intraocular 
pressure. During the follow-up period, complications 
such as endophthalmitis, retinal folds, and choroidal 
Fig. 3 a–i Color fundus photographs, fluorescein angiography, and optical coherence tomography from one of the 8 rabbits at the baseline (a–c), 
3 months (d–f), and 6 months (g–i) follow-up intervals. No retinal abnormalities were observed during the follow-up period
Page 6 of 7Lima et al. Int J Retin Vitr  (2016) 2:23 
detachment were not observed. All rabbits underwent 
successful closure of 20-gauge sclerotomy wounds when 
scleral temperature was above 32 °C. The wound closure 
created by pNIPAM was sufficient in all cases to maintain 
tissue apposition throughout the experimental period, i.e. 
to 14 days, 1 month, and 6 months.
Although the present study addressed only the closure of 
perpendicular 20-gauge sclerotomies by PNIPAM, future 
research in this field may focus on the feasibility of PNI-
PAM for closing transconjunctival and oblique 23, 25 and 
27-gauge sclerotomies performed in the current microin-
cision vitrectomy surgery (MIVS). Since we showed the 
conjunctiva around the scleral incision was normal with-
out any inflammatory reaction  1-month after PNIPAM 
application, it is probable that this polymer has the poten-
tial for closing transconjuctival MIVS sclerotomies.
Conclusion
Our study demonstrated that pNIPAM can be attached 
from the scleral surface, merely by changing the tempera-
ture of the scleral tissue. Theoretically, this reversibility 
property may offer the capability to remove the pNIPAM-
sclera adhesion whenever necessary solely by using a 
lower temperature BSS in infusion. pNIPAM with micro-
fabrication and patterning may have the potential to be 
used as a nanotechnological system for sutureless sclerot-
omies closure. In addition, pNIPAM also can have other 
uses in drug-delivery and ocular procedures. In conclu-
sion, although clinical studies are required to evaluate its 
utility in patients undergoing pars plana vitrectomy, pNI-
PAM when used at a proper temperature seems to have 
the potential to be used as a thermosensitive reversible 
adhesive for 20-gauge scleral wound closure.
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